Saturday, October 01, 2016 6:21:56 AM
LOL ...Well Pope, comparing the Plague to Zika is probably a bit of a stretch but since you brought it up: did you know what the simple remedy that would have saved those millions of people in the middle ages was? Penicillin! Yep...we should all be thankful that we have real researchers that develop cures such as penicillin just like we should be thankful that today's researchers are close to a Zika vaccine and anti-viral agents that will shortly be the end of Zika.
Dr. Mawanda was not saved by the HP. I am not going to go back and dig up the previous exact quotes but its well documented and discussed on this board that the virus was already in decline due to 1) the natural progression of the disease and 2) the anti-viral agents given. Its like if a football team is winning 49-0 and brings in the 3rd string quarterback in the 4th quarter to finish the game and then the 3rd string quarterback claims they won the game! Dr. Mawanda himself has never given credit to the HP - if you can find proof he has given credit to the HP (not JJ claiming credit) please post it here. Again, for someone that loves to quote the bible Pope you sure are only interested in truth that benefits you...
Aethlons motto is "Save Lives" but in their entire 16 year history, this 5 person "company" has never saved a single life! I know lifeguards that save more lives in a day than this sham will ever save...TRUTH
Proverbs 13:11 "Dishonest money dwindles away..." This verse reminds me of the almost $100M in investor money this sham has wasted over 16 years with no lives saved and no product released to the market now or anytime in the near future
Recent AEMD News
- Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices • PR Newswire (US) • 02/21/2024 01:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 10:15:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:15:41 PM
- Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update • PR Newswire (US) • 02/14/2024 09:15:00 PM
- Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024 • PR Newswire (US) • 02/07/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:06:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:04:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:02:52 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:01:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 12:49:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:15:39 PM
- Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update • PR Newswire (US) • 11/14/2023 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 01:01:36 PM
- Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer • PR Newswire (US) • 11/13/2023 01:01:00 PM
- Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023 • PR Newswire (US) • 11/06/2023 01:01:00 PM
- Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology • PR Newswire (US) • 10/10/2023 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 09:05:12 PM
- Aethlon Announces Reverse Stock Split • PR Newswire (US) • 10/04/2023 12:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/29/2023 09:57:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/29/2023 09:56:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/29/2023 09:54:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 01:00:08 PM
- Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference • PR Newswire (US) • 08/30/2023 12:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 09:15:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:20:32 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM